| Characteristics | Frequency (%) |
| Chronic illness |
|
| Yes | 166 (40.2%) |
| No | 247 (59.8%) |
| Types of chronic diseases |
|
| Diabetes Mellitus | 64 (15.5%) |
| Hypertension | 60 (14.5%) |
| Thyroid diseases | 52 (12.6%) |
| Asthma | 46 (11.1%) |
| Renal diseases | 8 (1.9%) |
| Low immunity | 3 (0.7%) |
| cancer | 2 (0.5%) |
| Others |
|
| Cardiac problems | 5 (1.1%) |
| Arthritis | 2 (0.4%) |
| Epilepsy & Facial palsy | 2 (0.4%) |
| Flu vaccine |
|
| Yes | 60 (14.5%) |
| No | 352 (85.2%) |
| COVID-19 vaccine |
|
| Yes | 382 (92.5%) |
| No | 28 (6.8%) |
| Types of COVID-19 vaccine |
|
| Strazinka | 93 (22.5%) |
| Pfizer | 236 (57.1%) |
| Mixed | 34 (8.2%) |
| Jonson & Jonson | 2 (0.5%) |
| Unknown | 25 (6.1%) |
| Other | 7 (1.7%) |
| Admitted to hospital |
|
| In-home isolation | 371 (89.8%) |
| Ward patient | 37 (9.0%) |
| ICU | 5 (1.2%) |
| Isolation days per week |
|
| <1 week | 5 (1.2%) |
| 1 - 2 weeks | 282 (69.3%) |
| 3 - 4 weeks | 102 (25.1%) |
| <4 weeks | 18 (4.4%) |
| Symptoms continue after 2 weeks |
|
| Yes | 174 (42.1%) |
| No | 239 (57.9%) |
| Duration of COVID-19 Symptoms per week |
|
| <1 week | 199 (48.9%) |
| 1 - 2 weeks | 163 (40.0%) |
| 3 - 4 weeks | 29 (7.1%) |
| <4 weeks | 16 (4.0%) |
| Swab after recovery |
|
| Yes | 85 (20.6%) |
| No | 328 (79.4%) |
| Is the disease worsening the quality of life? |
|
| Yes | 43 (10.4%) |
| No | 370 (89.6%) |
| Patients’ Medications |
|
| Analgesics, zinc, and vitamin c | 136 (32.9%) |
| Analgesics, Herbal medication, and vitamin c | 108 (26.2%) |
| Respiratory supportive therapy (oxygen, Ventolin), Azithromycin, analgesics, zinc, vitamin c | 54 (13.1%) |
| vitamin c, zinc | 49 (11.9%) |
| Analgesics, azithromycin | 29 (7.0%) |
| Respiratory supportive therapy (oxygen, Ventolin), Azithromycin, analgesics, anticoagulant, and zinc | 15 (3.6%) |